248 related articles for article (PubMed ID: 35503786)
1. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
[TBL] [Abstract][Full Text] [Related]
2. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
3. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
[TBL] [Abstract][Full Text] [Related]
5. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
6. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
[TBL] [Abstract][Full Text] [Related]
7. The blackfly vectors and transmission of Onchocerca volvulus in Mahenge, south eastern Tanzania.
Hendy A; Krüger A; Pfarr K; De Witte J; Kibweja A; Mwingira U; Dujardin JC; Post R; Colebunders R; O'Neill S; Kalinga A
Acta Trop; 2018 May; 181():50-59. PubMed ID: 29410302
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
[TBL] [Abstract][Full Text] [Related]
9. The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
Abong RA; Amambo GN; Hamid AA; Enow BA; Beng AA; Nietcho FN; Nji TM; Njouendou AJ; Ritter M; Esum ME; Deribe K; Cho JF; Fombad FF; Enyong PI; Poole C; Pfarr K; Hoerauf A; Carlow C; Wanji S
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008926. PubMed ID: 33465080
[TBL] [Abstract][Full Text] [Related]
10. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
[TBL] [Abstract][Full Text] [Related]
11. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
12. Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum.
Hendy A; Krit M; Pfarr K; Laemmer C; De Witte J; Nwane P; Kamgno J; Nana-Djeunga HC; Boussinesq M; Dujardin JC; Post R; Colebunders R; O'Neill S; Enyong P; Njamnshi AK
Parasit Vectors; 2021 Nov; 14(1):563. PubMed ID: 34727965
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and cytokines in patients with an occult Onchocerca volvulus infection.
Lechner CJ; Gantin RG; Seeger T; Sarnecka A; Portillo J; Schulz-Key H; Karabou PK; Helling-Giese G; Heuschkel C; Banla M; Soboslay PT
Microbes Infect; 2012 May; 14(5):438-46. PubMed ID: 22202179
[TBL] [Abstract][Full Text] [Related]
14. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
15. Reductions in microfilaridermia by repeated ivermectin treatment are associated with lower Plasmodium-specific Th17 immune responses in Onchocerca volvulus-infected individuals.
Arndts K; Klarmann-Schulz U; Batsa L; Debrah AY; Epp C; Fimmers R; Specht S; Layland LE; Hoerauf A
Parasit Vectors; 2015 Mar; 8():184. PubMed ID: 25889652
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.
Soboslay PT; Dreweck CM; Hoffmann WH; Lüder CG; Heuschkel C; Görgen H; Banla M; Schulz-Key H
Clin Exp Immunol; 1992 Sep; 89(3):407-13. PubMed ID: 1516257
[TBL] [Abstract][Full Text] [Related]
17. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
Eisenbarth A; Achukwi MD; Renz A
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004392. PubMed ID: 26926855
[TBL] [Abstract][Full Text] [Related]
18. Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca volvulus in man.
Wahl G; Enyong P; Ngosso A; Schibel JM; Moyou R; Tubbesing H; Ekale D; Renz A
Parasitology; 1998 Apr; 116 ( Pt 4)():349-62. PubMed ID: 9585937
[TBL] [Abstract][Full Text] [Related]
19. Entomological assessment of the transmission following recrudescence of onchocerciasis in the Comoé Valley, Burkina Faso.
Koala L; Nikièma AS; Paré AB; Drabo F; Toé LD; Belem AMG; Boakye DA; Traoré S; Dabiré RK
Parasit Vectors; 2019 Jan; 12(1):34. PubMed ID: 30646934
[TBL] [Abstract][Full Text] [Related]
20. Onchocerciasis in the Cameroon-Chad border area after more than 20 years of annual mass ivermectin distribution.
Ayisi F; de Souza DK; Tallant J; Biholong BD; Fokam EB; Boakye DA
Parasit Vectors; 2024 May; 17(1):219. PubMed ID: 38741212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
